| 2024年中报 | 2023年年报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医疗器械(元) | - | - | 1,143,008.87 | 284,601.77 |
| 原料药(元) | - | - | - | 18,417,889.51 |
| 磷酸氢钙(元) | 11,620,451.40 | 23,195,860.69 | 19,866,253.49 | - |
| 乳酸(元) | 3,220,729.25 | 6,339,874.05 | 3,880,217.50 | - |
| 乳酸钙(元) | 4,966,639.95 | 15,506,098.53 | 12,441,194.67 | - |
| 乳酸钠溶液(元) | 3,891,143.35 | 10,372,218.56 | 8,557,437.30 | - |
| 左乙拉西坦口服溶液(元) | 3,185.84 | - | - | - |
| 营业成本(元) | ||||
| 医疗器械(元) | - | - | 735,929.22 | 222,654.89 |
| 原料药(元) | - | - | - | 7,243,636.36 |
| 磷酸氢钙(元) | 4,725,977.35 | 10,193,573.26 | 10,065,327.65 | - |
| 乳酸(元) | 2,336,128.24 | 4,022,549.38 | 2,156,205.07 | - |
| 乳酸钙(元) | 1,476,436.22 | 2,980,120.79 | 2,636,744.30 | - |
| 乳酸钠溶液(元) | 2,500,736.40 | 6,273,069.26 | 5,185,898.18 | - |
| 左乙拉西坦口服溶液(元) | 3,831.56 | - | - | - |
| 毛利(元) | ||||
| 医疗器械(元) | - | - | 407,079.65 | 61,946.88 |
| 原料药(元) | - | - | - | 11,174,253.15 |
| 磷酸氢钙(元) | 6,894,474.05 | 13,002,287.43 | 9,800,925.84 | - |
| 乳酸(元) | 884,601.01 | 2,317,324.67 | 1,724,012.43 | - |
| 乳酸钙(元) | 3,490,203.73 | 12,525,977.74 | 9,804,450.37 | - |
| 乳酸钠溶液(元) | 1,390,406.95 | 4,099,149.30 | 3,371,539.12 | - |
| 左乙拉西坦口服溶液(元) | -645.72 | - | - | - |
| 毛利率(%) | ||||
| 医疗器械(%) | - | - | 35.61 | 21.77 |
| 原料药(%) | - | - | - | 60.67 |
| 磷酸氢钙(%) | 59.33 | 56.05 | 49.33 | - |
| 乳酸(%) | 27.47 | 36.55 | 44.43 | - |
| 乳酸钙(%) | 70.27 | 80.78 | 78.81 | - |
| 乳酸钠溶液(%) | 35.73 | 39.52 | 39.40 | - |
| 左乙拉西坦口服溶液(%) | -20.27 | - | - | - |
| 收入构成(%) | ||||
| 医疗器械(%) | - | - | 2.49 | 1.52 |
| 原料药(%) | - | - | - | 98.48 |
| 磷酸氢钙(%) | 49.03 | 41.86 | 43.29 | - |
| 乳酸(%) | 13.59 | 11.44 | 8.46 | - |
| 乳酸钙(%) | 20.95 | 27.98 | 27.11 | - |
| 乳酸钠溶液(%) | 16.42 | 18.72 | 18.65 | - |
| 左乙拉西坦口服溶液(%) | 0.01 | - | - | - |
| 毛利构成(%) | ||||
| 医疗器械(%) | - | - | 1.62 | 0.55 |
| 原料药(%) | - | - | - | 99.45 |
| 磷酸氢钙(%) | 54.46 | 40.70 | 39.04 | - |
| 乳酸(%) | 6.99 | 7.25 | 6.87 | - |
| 乳酸钙(%) | 27.57 | 39.21 | 39.05 | - |
| 乳酸钠溶液(%) | 10.98 | 12.83 | 13.43 | - |
| 左乙拉西坦口服溶液(%) | -0.01 | - | - | - |